CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-10 | Chung Christine SVP, China Operations | Sale | −4,692 | $20.20 | $95K | 261,964 |
| 2023-03-10 | Chung Christine SVP, China Operations | Sale | −2,914 | $20.20 | $59K | 259,050 |
| 2023-03-10 | Conterno Enrique A Chief Executive Officer | Sale | −12,103 | $20.20 | $244K | 404,357 |
| 2023-03-10 | Conterno Enrique A Chief Executive Officer | Sale | −19,486 | $20.20 | $394K | 384,868 |
| 2023-03-10 | Eisner Mark Chief Medical Officer | Sale | −3,885 | $20.20 | $78K | 181,431 |
| 2023-03-10 | Eisner Mark Chief Medical Officer | Sale | −6,255 | $20.20 | $126K | 175,176 |
| 2023-03-10 | Graham Juan Chief Financial Officer | Sale | −1,112 | $20.20 | $22K | 76,668 |
| 2023-03-10 | Graham Juan Chief Financial Officer | Sale | −1,456 | $20.20 | $29K | 75,212 |
| 2023-03-10 | Graham Juan Chief Financial Officer | Sale | −2,344 | $20.20 | $47K | 72,868 |
| 2023-03-10 | Wettig Thane Chief Commercial Officer | Sale | −2,938 | $20.20 | $59K | 116,289 |
| 2023-03-10 | Wettig Thane Chief Commercial Officer | Sale | −4,731 | $20.20 | $96K | 111,558 |
| 2023-03-08 | Chung Christine SVP, China Operations | Sale | −8,354 | $21.16 | $177K | 251,519 |
| 2023-03-08 | Chung Christine SVP, China Operations | Grant or award | +5,799 | 257,318 | ||
| 2023-03-08 | Chung Christine SVP, China Operations | Grant or award | +9,338 | 266,656 | ||
| 2023-03-08 | Conterno Enrique A Chief Executive Officer | Sale | −24,672 | $21.16 | $522K | 356,111 |
| 2023-03-08 | Conterno Enrique A Chief Executive Officer | Grant or award | +23,120 | 379,231 | ||
| 2023-03-08 | Conterno Enrique A Chief Executive Officer | Grant or award | +37,229 | 416,460 | ||
| 2023-03-08 | Eisner Mark Chief Medical Officer | Sale | −7,363 | $21.16 | $156K | 165,133 |
| 2023-03-08 | Eisner Mark Chief Medical Officer | Grant or award | +7,732 | 172,865 | ||
| 2023-03-08 | Eisner Mark Chief Medical Officer | Grant or award | +12,451 | 185,316 |
Page 9 of 16 · 320 trades